wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34132872-2748CEE9-C11E-44F3-A8AC-A29898481AE6
Q34132872-2748CEE9-C11E-44F3-A8AC-A29898481AE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34132872-2748CEE9-C11E-44F3-A8AC-A29898481AE6
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.
P2860
Q34132872-2748CEE9-C11E-44F3-A8AC-A29898481AE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34132872-2748CEE9-C11E-44F3-A8AC-A29898481AE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
869aa01aadcd0a11d0c882d5146302742b10152e
P2860
Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy